Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors

PLoS Pathogens

Volumn 13, Issue 10, 2017, Pages

  Cepeda Molero, Massiel ^a   Berger, Cedric N ^b   Walsham, Alistair D S ^c,d   Ellis, Samuel J ^c,d   Wemyss Holden, Simon ^e   Schüller, Stephanie ^c,d   Frankel, Gad ^b   Fernández, Luis Ángel ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CHAPERONIN; INTIMIN; MUCIN; PROTEIN TRANSLOCASE; SYNAPTOTAGMIN I; ADHESIN; CARRIER PROTEIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONFOCAL MICROSCOPY; DNA FLANKING REGION; DNA MODIFICATION; DNA SEQUENCE; ENTEROCYTE EFFACEMENT; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE CLUSTER; GENE EXPRESSION; GENE INSERTION SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTESTINE BIOPSY; INTESTINE CELL; INTESTINE INJURY; INTESTINE MUCOSA; NONHUMAN; PATHOGENICITY; PHENOTYPE; PLASMID; PROPHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TYPE III SECRETION SYSTEM; WESTERN BLOTTING; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; GENOMIC ISLAND; METABOLISM; MICROBIOLOGY;

ADHESINS, BACTERIAL; CARRIER PROTEINS; ENTEROCYTES; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENOMIC ISLANDS; HUMANS; INTESTINAL MUCOSA;

EID: 85033220930     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006706     Document Type: Article

References (61)

1. Kim M, Ashida H, Ogawa M, Yoshikawa Y, Mimuro H, Sasakawa C, Bacterial interactions with the host epithelium. Cell Host Microbe. 2010;8(1):20–35. doi: 10.1016/j.chom.2010.06.006 20638639.
2. Galán JE, Lara-Tejero M, Marlovits TC, Wagner S, Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells. Annu Rev Microbiol. 2014;68:415–38. Epub 2014/07/09. doi: 10.1146/annurev-micro-092412-155725 25002086.
3. Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA, Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun. 1983;41(3):1340–51. 6350186.
4. Lai Y, Rosenshine I, Leong JM, Frankel G, Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol. 2013;15(11):1796–808. Epub 2013/08/10. doi: 10.1111/cmi.12179 23927593; PubMed Central PMCID: PMC4036124.
5. McDaniel TK, Kaper JB, A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol Microbiol. 1997;23(2):399–407. 9044273.
6. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng YK, Lai LC, et al. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol. 1998;28(1):1–4. Epub 1998/05/21. 9593291.
7. Gaytán MO, Martínez-Santos VI, Soto E, González-Pedrajo B, Type Three Secretion System in Attaching and Effacing Pathogens. Frontiers in cellular and infection microbiology. 2016;6:129. Epub 2016/11/08. doi: 10.3389/fcimb.2016.00129 27818950; PubMed Central PMCID: PMCPMC5073101.
8. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB, Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell. 1997;91(4):511–20. 9390560
9. Frankel G, Phillips AD, Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol. 2008;10(3):549–56. Epub 2007/12/07. doi: 10.1111/j.1462-5822.2007.01103.x 18053003.
10. Schüller S, Chong Y, Lewin J, Kenny B, Frankel G, Phillips AD, Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol. 2007;9(5):1352–64. Epub 2007/05/04. CMI879 [pii] doi: 10.1111/j.1462-5822.2006.00879.x 17474908.
11. Guttman JA, Finlay BB, Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol. 2008;16(11):535–42. Epub 2008/09/30. S0966-842X(08)00195-9 [pii] doi: 10.1016/j.tim.2008.08.004 18819802.
12. Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80(6):1420–38. Epub 2011/04/15. doi: 10.1111/j.1365-2958.2011.07661.x 21488979.
13. Berger CN, Crepin VF, Jepson MA, Arbeloa A, Frankel G, The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell Microbiol. 2009;11(2):309–22. Epub 2008/12/03. CMI1254 [pii] doi: 10.1111/j.1462-5822.2008.01254.x 19046338.
14. Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, et al. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol. 2009;16(8):853–60. Epub 2009/07/22. doi: 10.1038/nsmb.1647 19620963; PubMed Central PMCID: PMCPMC5130228.
15. Dong N, Liu L, Shao F, A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis. EMBO J. 2010;29(8):1363–76. Epub 2010/03/20. doi: 10.1038/emboj.2010.33 20300064; PubMed Central PMCID: PMC2868573.
16. Wong AR, Clements A, Raymond B, Crepin VF, Frankel G, The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH. MBio. 2012;3(1). Epub 2012/01/19. doi: 10.1128/mBio.00250-11 22251971; PubMed Central PMCID: PMC3374388.
17. Furniss RCD, Slater S, Frankel G, Clements A, Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection. Journal of Molecular Biology. 2016;428(17):3399–407. doi: 10.1016/j.jmb.2016.05.023 27261256
18. Glotfelty LG, Zahs A, Hodges K, Shan K, Alto NM, Hecht GA, Enteropathogenic E. coli Effectors EspG1/G2 Disrupt Microtubules, Contribute to Tight Junction Perturbation and Inhibit Restoration. Cell Microbiol. 2014. Epub 2014/06/21. doi: 10.1111/cmi.12323 24948117.
19. Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G, EspZ of Enteropathogenic and Enterohemorrhagic Escherichia coli Regulates Type III Secretion System Protein Translocation. mBio. 2012;3(5). Epub 2012/10/04. doi: 10.1128/mBio.00317-12 23033475.
20. Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, Henderson IR, et al. Complete Genome Sequence and Comparative Genome Analysis of Enteropathogenic Escherichia coli O127:H6 Strain E2348/69. J Bacteriol. 2009;191(1):347–54. doi: 10.1128/JB.01238-08 18952797
21. Santos AS, Finlay BB, Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways. Cell Microbiol. 2015;17(3):318–32. Epub 2015/01/16. doi: 10.1111/cmi.12412 25588886.
22. Pallett MA, Crepin VF, Serafini N, Habibzay M, Kotik O, Sanchez-Garrido J, et al. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells. Mucosal Immunol. 2017;10(3):602–12. Epub 2016/09/15. doi: 10.1038/mi.2016.77 27624779; PubMed Central PMCID: PMCPMC5159625.
23. Wong Fok Lung T, Pearson JS, Schuelein R, Hartland EL, The cell death response to enteropathogenic Escherichia coli infection. Cell Microbiol. 2014;16(12):1736–45. Epub 2014/10/01. doi: 10.1111/cmi.12371 25266336.
24. Pearson JS, Riedmaier P, Marches O, Frankel G, Hartland EL, A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol Microbiol. 2011;80(1):219–30. Epub 2011/02/11. doi: 10.1111/j.1365-2958.2011.07568.x 21306441.
25. Deng W, Yu HB, de Hoog CL, Stoynov N, Li Y, Foster LJ, et al. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens. Mol Cell Proteomics. 2012;11(9):692–709. Epub 2012/06/05. doi: 10.1074/mcp.M111.013672 22661456; PubMed Central PMCID: PMC3434768.
26. Klapproth JM, Scaletsky IC, McNamara BP, Lai LC, Malstrom C, James SP, et al. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun. 2000;68(4):2148–55. 10722613; PubMed Central PMCID: PMCPMC97397.
27. Klapproth JM, The role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infection. Toxins (Basel). 2010;2(5):954–62. Epub 2010/05/01. doi: 10.3390/toxins2050954 22069619; PubMed Central PMCID: PMC3153230.
28. Klapproth JM, Sasaki M, Sherman M, Babbin B, Donnenberg MS, Fernandes PJ, et al. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect Immun. 2005;73(3):1441–51. Epub 2005/02/26. doi: 10.1128/IAI.73.3.1441-1451.2005 15731042; PubMed Central PMCID: PMC1064951.
29. Abu-Median AB, van Diemen PM, Dziva F, Vlisidou I, Wallis TS, Stevens MP, Functional analysis of lymphostatin homologues in enterohaemorrhagic Escherichia coli. FEMS Microbiol Lett. 2006;258(1):43–9. doi: 10.1111/j.1574-6968.2006.00198.x 16630253.
30. Knutton S, Lloyd DR, McNeish AS, Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun. 1987;55(1):69–77. Epub 1987/01/01. 3539808.
31. Hicks S, Frankel G, Kaper JB, Dougan G, Phillips AD, Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect Immun. 1998;66(4):1570–8. 9529083.
32. Phillips AD, Frankel G, Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures. J Infect Dis. 2000;181(4):1496–500. Epub 2000/04/14. doi: 10.1086/315404 10762584.
33. Shaw RK, Cleary J, Murphy MS, Frankel G, Knutton S, Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect Immun. 2005;73(2):1243–51. Epub 2005/01/25. doi: 10.1128/IAI.73.2.1243-1251.2005 15664974; PubMed Central PMCID: PMC547083.
34. Posfai G, Kolisnychenko V, Bereczki Z, Blattner FR, Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome. Nucleic Acids Res. 1999;27(22):4409–15. 10536150.
35. Battle SE, Brady MJ, Vanaja SK, Leong JM, Hecht GA, Actin Pedestal Formation by Enterohemorrhagic Escherichia coli Enhances Bacterial Host Cell Attachment and Concomitant Type III Translocation. Infection and Immunity. 2014;82(9):3713–22. doi: 10.1128/IAI.01523-13 24958711
36. Vidal JE, Navarro-Garcia F, EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell Microbiol. 2008;10(10):1975–86. Epub 2008/06/13. CMI1181 [pii] doi: 10.1111/j.1462-5822.2008.01181.x 18547338.
37. Tejeda-Dominguez F, Huerta-Cantillo J, Chavez-Dueñas L, Navarro-Garcia F, A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins. mBio. 2017;8(2). doi: 10.1128/mBio.00184-17 28351918
38. Guignot J, Segura A, Tran Van Nhieu G, The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System. PLoS Pathog. 2015;11(7):e1005013. Epub 2015/07/02. doi: 10.1371/journal.ppat.1005013 26132339.
39. Serapio-Palacios A, Navarro-Garcia F, EspC, an Autotransporter Protein Secreted by Enteropathogenic Escherichia coli, Causes Apoptosis and Necrosis through Caspase and Calpain Activation, Including Direct Procaspase-3 Cleavage. MBio. 2016;7(3). Epub 2016/06/23. doi: 10.1128/mBio.00479-16 27329750; PubMed Central PMCID: PMC4916375.
40. Navarro-Garcia F, Serapio-Palacios A, Vidal JE, Salazar MI, Tapia-Pastrana G, EspC promotes epithelial cell detachment by enteropathogenic Escherichia coli via sequential cleavages of a cytoskeletal protein and then focal adhesion proteins. Infect Immun. 2014;82(6):2255–65. Epub 2014/03/20. doi: 10.1128/IAI.01386-13 24643541; PubMed Central PMCID: PMC4019189.
41. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, Abe A, Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A. 2001;98(20):11638–43. Epub 2001/09/20. doi: 10.1073/pnas.191378598 191378598 [pii]. 11562461; PubMed Central PMCID: PMC58782.
42. Sohel I, Puente JL, Ramer SW, Bieber D, Wu CY, Schoolnik GK, Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J Bacteriol. 1996;178(9):2613–28. 8626330; PubMed Central PMCID: PMCPMC177987.
43. Charpentier X, Oswald E, Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol. 2004;186(16):5486–95. doi: 10.1128/JB.186.16.5486-5495.2004 15292151.
44. Blanco-Toribio A, Muyldermans S, Frankel G, Fernández LA, Direct injection of functional single-domain antibodies from E. coli into human cells. PLoS ONE. 2010;5(12):e15227. Epub 2010/12/21. doi: 10.1371/journal.pone.0015227 21170340; PubMed Central PMCID: PMC2999559.
45. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog. 2010;6(5):e1000898. doi: 10.1371/journal.ppat.1000898 20485572; PubMed Central PMCID: PMCPMC2869321.
46. Gao X, Wang X, Pham Thanh H, Feuerbacher Leigh A, Lubos M-L, Huang M, et al. NleB, a Bacterial Effector with Glycosyltransferase Activity, Targets GADPH Function to Inhibit NF-κB Activation. Cell Host &Microbe. 2013;13(1):87–99. doi: 10.1016/j.chom.2012.11.010 23332158; PubMed Central PMCID: PMCPMC3553500.
47. Hodgson A, Wier EM, Fu K, Sun X, Yu H, Zheng W, et al. Metalloprotease NleC suppresses host NF-kappaB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction. PLoS Pathog. 2015;11(3):e1004705. doi: 10.1371/journal.ppat.1004705 25756944; PubMed Central PMCID: PMCPMC4355070.
48. Ochoa TJ, Contreras CA, Enteropathogenic E. coli (EPEC) infection in children. Current opinion in infectious diseases. 2011;24(5):478–83. doi: 10.1097/QCO.0b013e32834a8b8b PMC3277943; PubMed Central PMCID: PMCPMC3277943. 21857511
49. Clements A, Young J, Constantinou N, Frankel G, Infection strategies of enteric pathogenic E. coli. Gut Microbes. 2012;3(2). Epub 2012/05/05. doi: 10.4161/gmic.19182 22555463.
50. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I, Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe. 2008;3(2):104–13. Epub 2008/03/04. S1931-3128(07)00309-5 [pii] doi: 10.1016/j.chom.2007.11.007 18312845.
51. Nadler C, Baruch K, Kobi S, Mills E, Haviv G, Farago M, et al. The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog. 2010;6(1):e1000743. doi: 10.1371/journal.ppat.1000743 20126447; PubMed Central PMCID: PMCPMC2813277.
52. Morabito S, Tozzoli R, Oswald E, Caprioli A, A Mosaic Pathogenicity Island Made Up of the Locus of Enterocyte Effacement and a Pathogenicity Island of Escherichiacoli O157:H7 Is Frequently Present in Attaching and Effacing E. coli. Infection and Immunity. 2003;71(6):3343–8. doi: 10.1128/IAI.71.6.3343-3348.2003 12761117
53. Deacon V, Dziva F, van Diemen PM, Frankel G, Stevens MP, Efa-1/LifA mediates intestinal colonization of calves by enterohaemorrhagic Escherichia coli O26:H- in a manner independent of glycosyltransferase and cysteine protease motifs or effects on type III secretion. Microbiology. 2010;156(8):2527–36. doi: 10.1099/mic.0.039685–0
54. Badea L, Doughty S, Nicholls L, Sloan J, Robins-Browne RM, Hartland EL, Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells. Microb Pathog. 2003;34(5):205–15. 12732469.
55. Nicholls L, Grant TH, Robins-Browne RM, Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol Microbiol. 2000;35(2):275–88. Epub 2000/01/29. 10652089.
56. Babbin BA, Sasaki M, Gerner-Schmidt KW, Nusrat A, Klapproth JM, The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases. Am J Pathol. 2009;174(4):1347–57. doi: 10.2353/ajpath.2009.080640 19286565; PubMed Central PMCID: PMCPMC2671366.
57. Ruano-Gallego D, Álvarez B, Fernández LÁ, Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells. ACS synthetic biology. 2015;4(9):1030–41. doi: 10.1021/acssynbio.5b00080 26017572
58. Jurado P, Ritz D, Beckwith J, de Lorenzo V, Fernández LA, Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J Mol Biol. 2002;320(1):1–10. doi: 10.1016/S0022-2836(02)00405-9 12079330
59. Bodelón G, Marín E, Fernández LA, Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of Intimin from enteropathogenic Escherichia coli strains. J Bacteriol. 2009;191(16):5169–79. doi: 10.1128/JB.00458-09 19525348
60. Lewis SB, Cook V, Tighe R, Schüller S, Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo. Infect Immun. 2015;83(3):942–9. doi: 10.1128/IAI.02928-14 25534942; PubMed Central PMCID: PMCPMC4333473.
61. Pallett MA, Berger CN, Pearson JS, Hartland EL, Frankel G, The Type III Secretion Effector NleF of Enteropathogenic Escherichia coli Activates NF-kappaB Early during Infection. Infect Immun. 2014;82(11):4878–88. Epub 2014/09/04. doi: 10.1128/IAI.02131-14 25183730.